• Je něco špatně v tomto záznamu ?

Two novel mutations in seven Czech and Slovak kindreds with familial neurohypophyseal diabetes insipidus-benefit of genetic testing

G. Hrčková, V. Jankó, J. Kytnarová, M. Čižmárová, M. Tesařová, Ľ. Košťálová, D. Virgová, T. Dallos, V. Hána, J. Lebl, J. Zeman, L. Kovács,

. 2016 ; 175 (9) : 1199-1207. [pub] 20160818

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17023761
E-zdroje Online Plný text

NLK ProQuest Central od 1996-01-01 do Před 1 rokem
CINAHL Plus with Full Text (EBSCOhost) od 2012-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 1997-01-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest) od 1996-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1996-01-01 do Před 1 rokem
Family Health Database (ProQuest) od 1996-01-01 do Před 1 rokem
Public Health Database (ProQuest) od 1996-01-01 do Před 1 rokem

UNLABELLED: Familial neurohypophyseal diabetes insipidus (FNDI) is a rare hereditary disorder with unknown prevalence characterized by arginine-vasopressin hormone (AVP) deficiency resulting in polyuria and polydipsia from early childhood. We report the clinical manifestation and genetic test results in seven unrelated kindreds of Czech or Slovak origin with FNDI phenotype. The age of the sign outset ranged from 2 to 17 years with remarkable interfamilial and intrafamilial variability. Inconclusive result of the fluid deprivation test in three children aged 7 and 17 years old might cause misdiagnosis; however, the AVP gene analysis confirmed the FNDI. The seven families segregated together five different mutations, two of them were novel (c.164C > A, c.298G > C). In addition, DNA analysis proved mutation carrier status in one asymptomatic 1-year-old infant. CONCLUSIONS: The present study together with previously published data identified 38 individuals with FNDI in the studied population of 16 million which predicts a disease prevalence of 1:450,000 for the Central European region. The paper underscores that diagnostic water deprivation test may be inconclusive in polyuric children with partial diabetes insipidus and points to the clinical importance and feasibility of molecular genetic testing for AVP gene mutations in the proband and her/his first degree relatives. WHAT IS KNOWN: • At least 70 different mutations were reported to date in about 100 families with neurohypophyseal diabetes insipidus (FNDI), and new mutations appear sporadically. What is New: • Two novel mutations of the AVP gene are reported • The importance of molecular testing in children with polyuria and inconclusive water deprivation test is emphasized.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023761
003      
CZ-PrNML
005      
20171018082043.0
007      
ta
008      
170720s2016 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00431-016-2759-x $2 doi
035    __
$a (PubMed)27539621
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Hrčková, Gabriela $u 2nd Department of Pediatrics, Faculty of Medicine, Comenius University in Bratislava and University Children's Hospital Bratislava, Limbová 1, 833 40, Bratislava, Slovakia.
245    10
$a Two novel mutations in seven Czech and Slovak kindreds with familial neurohypophyseal diabetes insipidus-benefit of genetic testing / $c G. Hrčková, V. Jankó, J. Kytnarová, M. Čižmárová, M. Tesařová, Ľ. Košťálová, D. Virgová, T. Dallos, V. Hána, J. Lebl, J. Zeman, L. Kovács,
520    9_
$a UNLABELLED: Familial neurohypophyseal diabetes insipidus (FNDI) is a rare hereditary disorder with unknown prevalence characterized by arginine-vasopressin hormone (AVP) deficiency resulting in polyuria and polydipsia from early childhood. We report the clinical manifestation and genetic test results in seven unrelated kindreds of Czech or Slovak origin with FNDI phenotype. The age of the sign outset ranged from 2 to 17 years with remarkable interfamilial and intrafamilial variability. Inconclusive result of the fluid deprivation test in three children aged 7 and 17 years old might cause misdiagnosis; however, the AVP gene analysis confirmed the FNDI. The seven families segregated together five different mutations, two of them were novel (c.164C > A, c.298G > C). In addition, DNA analysis proved mutation carrier status in one asymptomatic 1-year-old infant. CONCLUSIONS: The present study together with previously published data identified 38 individuals with FNDI in the studied population of 16 million which predicts a disease prevalence of 1:450,000 for the Central European region. The paper underscores that diagnostic water deprivation test may be inconclusive in polyuric children with partial diabetes insipidus and points to the clinical importance and feasibility of molecular genetic testing for AVP gene mutations in the proband and her/his first degree relatives. WHAT IS KNOWN: • At least 70 different mutations were reported to date in about 100 families with neurohypophyseal diabetes insipidus (FNDI), and new mutations appear sporadically. What is New: • Two novel mutations of the AVP gene are reported • The importance of molecular testing in children with polyuria and inconclusive water deprivation test is emphasized.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a věk při počátku nemoci $7 D017668
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a arginin vasopresin $x genetika $7 D001127
650    _2
$a sekvence nukleotidů $7 D001483
650    _2
$a mozek $x diagnostické zobrazování $x patologie $7 D001921
650    _2
$a dítě $7 D002648
650    _2
$a Česká republika $x epidemiologie $7 D018153
650    _2
$a centrální diabetes insipidus $x epidemiologie $x genetika $7 D020790
650    _2
$a rodina $7 D005190
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetické testování $x metody $7 D005820
650    _2
$a heterozygot $7 D006579
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a magnetická rezonanční tomografie $7 D008279
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a mutace $7 D009154
650    _2
$a polydipsie $x etiologie $7 D059606
650    _2
$a polyurie $x etiologie $7 D011141
650    _2
$a prevalence $7 D015995
650    _2
$a Slovenská republika $x epidemiologie $7 D018154
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Jankó, Viktor $u 2nd Department of Pediatrics, Faculty of Medicine, Comenius University in Bratislava and University Children's Hospital Bratislava, Limbová 1, 833 40, Bratislava, Slovakia.
700    1_
$a Kytnarová, Jitka $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital Prague, Kateřinská 32, 121 08, Prague 2, Czech Republic.
700    1_
$a Čižmárová, Michaela $u 2nd Department of Pediatrics, Faculty of Medicine, Comenius University in Bratislava and University Children's Hospital Bratislava, Limbová 1, 833 40, Bratislava, Slovakia.
700    1_
$a Tesařová, Markéta $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital Prague, Kateřinská 32, 121 08, Prague 2, Czech Republic.
700    1_
$a Košťálová, Ľudmila $u 2nd Department of Pediatrics, Faculty of Medicine, Comenius University in Bratislava and University Children's Hospital Bratislava, Limbová 1, 833 40, Bratislava, Slovakia.
700    1_
$a Virgová, Daniela $u Department of Pediatrics, County Hospital Levice, SNP 19, 934 01, Levice, Slovakia.
700    1_
$a Dallos, Tomáš $u 2nd Department of Pediatrics, Faculty of Medicine, Comenius University in Bratislava and University Children's Hospital Bratislava, Limbová 1, 833 40, Bratislava, Slovakia.
700    1_
$a Hána, Václav $u 3rd Internal Clinic-Clinic of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital Prague, Kateřinská 32, 121 08, Prague 2, Czech Republic.
700    1_
$a Lebl, Jan $u Department of Pediatrics of the University Children's Hospital in Motol and 2nd Faculty of Medicine of Charles University in Prague, V Úvalu 84, 150 06, Prague 5, Czech Republic.
700    1_
$a Zeman, Jiří $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital Prague, Kateřinská 32, 121 08, Prague 2, Czech Republic.
700    1_
$a Kovács, László, $d 1950-2017 $7 xx0016705 $u 2nd Department of Pediatrics, Faculty of Medicine, Comenius University in Bratislava and University Children's Hospital Bratislava, Limbová 1, 833 40, Bratislava, Slovakia. kovacsbox@gmail.com.
773    0_
$w MED00009638 $t European journal of pediatrics $x 1432-1076 $g Roč. 175, č. 9 (2016), s. 1199-1207
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27539621 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20171018082116 $b ABA008
999    __
$a ok $b bmc $g 1239442 $s 984674
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 175 $c 9 $d 1199-1207 $e 20160818 $i 1432-1076 $m European journal of pediatrics $n Eur J Pediatr $x MED00009638
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace